Gujarat Themis Biosyn Ltd

BSE: 506879

29

total announcements

506879.BO · 15 min delayed

BSEAGM/EGMMgmt Change31 Jul 2026

Gujarat Themis Biosyn Ltd

Please refer to the attachment.

Gujarat Themis Biosyn Ltd has called an Extra-Ordinary General Meeting (EGM) on August 22, 2026, to consider approval of material related party transactions with promoter/promoter group entities and amendment to the Articles of Association.

Read more →📎 1 attachment
BSEAGM/EGM23 Jul 2026

Gujarat Themis Biosyn Ltd

Please refer to the Notice of Postal Ballot 22.07.2026

Gujarat Themis Biosyn Ltd has announced a Notice of Postal Ballot for approval of a resolution through remote e-voting. The resolution is proposed for approval of the Members of the Company by way of Postal Ballot through remote e-voting only. The notice is being sent only through electronic mode to those Members whose e-mail addresses are registered with the Company/Depository Participants.

Read more →📎 1 attachment
BSEInsider Trading / SASTPledge21 Jul 2026

Gujarat Themis Biosyn Ltd

The Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 ....

Gujarat Themis Biosyn Ltd has received a revised disclosure from Pharmaceutical Business Group (India) Ltd regarding the creation of an indirect encumbrance over 5,12,40,000 shares of the company held by PBGIL, a promoter group entity, due to a pledge of 25,24,245 shares and a non-disposal undertaking of 21,57,855 shares by Vividhmargi Investments Private Ltd in favor of CTL Trusteeship Ltd.

Read more →📎 1 attachment
BSEInsider Trading / SASTPledge21 Jul 2026

Gujarat Themis Biosyn Ltd

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 21, 2026 for Pharmaceutical ....

Gujarat Themis Biosyn Ltd has received a revised disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the creation of an indirect encumbrance over 5,12,40,000 shares of the company held by Pharmaceutical Business Group (India) Limited, a promoter group entity, due to a pledge of 25,24,245 shares of PBGIL by Vividhmargi Investments Private Limited in favour of CTL Trusteeship Limited.

Read more →📎 1 attachment
BSEInsider Trading / SASTPledge21 Jul 2026

Gujarat Themis Biosyn Ltd

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Pharmaceutical ....

Gujarat Themis Biosyn Ltd has received revised disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the release of 25,45,000 equity shares from pledge on 8th July, 2026.

Read more →📎 1 attachment
← PreviousPage 2 of 2